The impact of SGLT2 inhibitors on cardiac remodeling after myocardial infarction: an updated meta-analysis of randomized controlled trials.

Front Pharmacol · 2025 · PMC12696861 · PMID 41394153

Europe PMC DOI

hedged sentences

0.5200

closest p · 10.4× alpha

0.5200

boldest claim

The sentences

showed a trendp = 0.52not close (p > 0.1)

The results showed a trend toward reduced LVESVI in the experimental group compared to that in the control group (RR = 0.41, 95% CI −0.85 to 1.67; p = 0.52).

also in 53,322 other papers

a decreasing trendno p-value reported

In the 26-week subgroup, NT-proBNP showed a decreasing trend in the experimental group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.